
Indian pharma and biotech firm Wockhardt has been accused of violating current good manufacturing practice (CGMP) regulations in a letter …

Many women suffer from morning sickness during the early stages of pregnancy and some suffer from hyperemesis gravidarum, acute morning …

Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …

The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …

Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …

A blast at Sun Pharma’s Ahmednagar factory caused the deaths of two workers and injured a further two. The four …

In March 2016, Amgen won two major patent cases against Sanofi and Regeneron over their drug, Praleunt, after it was …

The state of Texas has filed a lawsuit against the FDA to try to force a decision to be made …

The investigation into practices by Novartis in its Greek operations has been accelerated after the attempted suicide of a Greek …

With a new year comes a fresh start, and so it was the case with Sanofi and MSD’s joint vaccine …

Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …
The FDA squeezed in one last approval before the year ended with the first approval for a drug to treat …

Seattle Genetics released that the FDA had placed a hold had been placed on clinical trials involving its experimental cancer …
Sanofi has sued Novo Nordisk over claims made in an advertising campaign for its drug Tresiba. Sanofi has filed the …

Sanofi and Boehringer Ingelheim have confirmed the successful completion of the exchange of Sanofi’s animal health business (Merial, based in …
Mylan ended a difficult year for itself by releasing a rash of generics into the market, ending the year strongly …
Pfizer has announced that they have acquired AstraZeneca’s small molecule anti-infectives business for an upfront fee of $550 million. Pfizer …

There have been new revelations regarding the fatal French clinical trial that occurred in January of this year. Nature reports …

Teva Pharmaceuticals, the world’s largest generics company, has been hit with the largest criminal fine to come from the US …